S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CNTX Context Therapeutics Inc

0.80

-0.031 (-3.73%)

Mar 07 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Context Therapeutics (NASDAQ:CNTX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Context Therapeutics Charts.

Context Therapeutics (NASDAQ:CNTX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Context Therapeutics Charts.

Context Therapeutics Inc News

Form 8-K - Current report
Friday 28 February 2025 (1 week ago) • Edgar (US Regulatory)

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Monday 24 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Context Therapeutics to Participate in Upcoming Investor Conferences
Wednesday 19 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 14 January 2025 (2 months ago) • Edgar (US Regulatory)

Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76
Tuesday 14 January 2025 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 13 January 2025 (2 months ago) • Edgar (US Regulatory)

Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors
Monday 13 January 2025 (2 months ago) • GlobeNewswire Inc.

More Context Therapeutics Inc News Articles

Asia Broadband (PK)

Kraig Biocraft Laborator... (QB)

Digital Brand Media and ... (PK)

Intergrated Cannabis Sol... (PK)

Lightwave Logic

Elite Pharmaceuticals (QB)

Northwest Biotherapeutics (QB)

Fannie Mae (QB)

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions